INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：状态是with editor 之后变成 decision in process，这个状态要持续多久呀，已经一个礼拜了，也不送审。可以直接投下一个期刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向：生物材料 经验分享：两个月了没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2166390, encodeId=9a102166390e1, content=cancer letters转投过来的，2023.10.25submit 2023.10.26with editor 2023.11.01under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0052564025, createdName=1256bf87m89暂无昵称, createdTime=Thu Nov 02 23:04:48 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2156965, encodeId=d654215696515, content=有大佬分享一下投稿时间线么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Sun Sep 10 09:07:05 CST 2023, time=2023-09-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158566, encodeId=6695215856645, content=这杂志咋进不去投稿界面？有没有知道咋回事的朋友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e48357893, createdName=ms6000001057089173, createdTime=Tue Sep 19 20:37:59 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156337, encodeId=2821215633e8e, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：6月2号提交，月底外审（中间变过两次日期），8月28号DIP，到现在没有信~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Wed Sep 06 09:22:18 CST 2023, time=2023-09-06, status=1, ipAttribution=北京)]

2023-09-11 Markxiao 来自香港

偏重的研究方向：分子生物学
经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢

37 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：状态是with editor 之后变成 decision in process，这个状态要持续多久呀，已经一个礼拜了，也不送审。可以直接投下一个期刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向：生物材料 经验分享：两个月了没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2166390, encodeId=9a102166390e1, content=cancer letters转投过来的，2023.10.25submit 2023.10.26with editor 2023.11.01under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0052564025, createdName=1256bf87m89暂无昵称, createdTime=Thu Nov 02 23:04:48 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2156965, encodeId=d654215696515, content=有大佬分享一下投稿时间线么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Sun Sep 10 09:07:05 CST 2023, time=2023-09-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158566, encodeId=6695215856645, content=这杂志咋进不去投稿界面？有没有知道咋回事的朋友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e48357893, createdName=ms6000001057089173, createdTime=Tue Sep 19 20:37:59 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156337, encodeId=2821215633e8e, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：6月2号提交，月底外审（中间变过两次日期），8月28号DIP，到现在没有信~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Wed Sep 06 09:22:18 CST 2023, time=2023-09-06, status=1, ipAttribution=北京)]

2023-11-25 ms2000001577708140 来自广东省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：医学
经验分享：状态是with editor 之后变成 decision in process，这个状态要持续多久呀，已经一个礼拜了，也不送审。可以直接投下一个期刊吗？

31 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：状态是with editor 之后变成 decision in process，这个状态要持续多久呀，已经一个礼拜了，也不送审。可以直接投下一个期刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向：生物材料 经验分享：两个月了没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2166390, encodeId=9a102166390e1, content=cancer letters转投过来的，2023.10.25submit 2023.10.26with editor 2023.11.01under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0052564025, createdName=1256bf87m89暂无昵称, createdTime=Thu Nov 02 23:04:48 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2156965, encodeId=d654215696515, content=有大佬分享一下投稿时间线么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Sun Sep 10 09:07:05 CST 2023, time=2023-09-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158566, encodeId=6695215856645, content=这杂志咋进不去投稿界面？有没有知道咋回事的朋友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e48357893, createdName=ms6000001057089173, createdTime=Tue Sep 19 20:37:59 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156337, encodeId=2821215633e8e, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：6月2号提交，月底外审（中间变过两次日期），8月28号DIP，到现在没有信~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Wed Sep 06 09:22:18 CST 2023, time=2023-09-06, status=1, ipAttribution=北京)]

2023-10-12 superzera 来自广东省

投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等

37 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：状态是with editor 之后变成 decision in process，这个状态要持续多久呀，已经一个礼拜了，也不送审。可以直接投下一个期刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向：生物材料 经验分享：两个月了没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2166390, encodeId=9a102166390e1, content=cancer letters转投过来的，2023.10.25submit 2023.10.26with editor 2023.11.01under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0052564025, createdName=1256bf87m89暂无昵称, createdTime=Thu Nov 02 23:04:48 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2156965, encodeId=d654215696515, content=有大佬分享一下投稿时间线么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Sun Sep 10 09:07:05 CST 2023, time=2023-09-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158566, encodeId=6695215856645, content=这杂志咋进不去投稿界面？有没有知道咋回事的朋友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e48357893, createdName=ms6000001057089173, createdTime=Tue Sep 19 20:37:59 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156337, encodeId=2821215633e8e, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：6月2号提交，月底外审（中间变过两次日期），8月28号DIP，到现在没有信~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Wed Sep 06 09:22:18 CST 2023, time=2023-09-06, status=1, ipAttribution=北京)]

2022-12-15 Marvin2014 来自江苏省

投稿一个月了，还在under review

52 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：状态是with editor 之后变成 decision in process，这个状态要持续多久呀，已经一个礼拜了，也不送审。可以直接投下一个期刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向：生物材料 经验分享：两个月了没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2166390, encodeId=9a102166390e1, content=cancer letters转投过来的，2023.10.25submit 2023.10.26with editor 2023.11.01under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0052564025, createdName=1256bf87m89暂无昵称, createdTime=Thu Nov 02 23:04:48 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2156965, encodeId=d654215696515, content=有大佬分享一下投稿时间线么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Sun Sep 10 09:07:05 CST 2023, time=2023-09-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158566, encodeId=6695215856645, content=这杂志咋进不去投稿界面？有没有知道咋回事的朋友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e48357893, createdName=ms6000001057089173, createdTime=Tue Sep 19 20:37:59 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156337, encodeId=2821215633e8e, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：6月2号提交，月底外审（中间变过两次日期），8月28号DIP，到现在没有信~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Wed Sep 06 09:22:18 CST 2023, time=2023-09-06, status=1, ipAttribution=北京)]

2023-06-06 gyoun9 来自北京

10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗

46 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：状态是with editor 之后变成 decision in process，这个状态要持续多久呀，已经一个礼拜了，也不送审。可以直接投下一个期刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向：生物材料 经验分享：两个月了没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2166390, encodeId=9a102166390e1, content=cancer letters转投过来的，2023.10.25submit 2023.10.26with editor 2023.11.01under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0052564025, createdName=1256bf87m89暂无昵称, createdTime=Thu Nov 02 23:04:48 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2156965, encodeId=d654215696515, content=有大佬分享一下投稿时间线么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Sun Sep 10 09:07:05 CST 2023, time=2023-09-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158566, encodeId=6695215856645, content=这杂志咋进不去投稿界面？有没有知道咋回事的朋友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e48357893, createdName=ms6000001057089173, createdTime=Tue Sep 19 20:37:59 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156337, encodeId=2821215633e8e, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：6月2号提交，月底外审（中间变过两次日期），8月28号DIP，到现在没有信~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Wed Sep 06 09:22:18 CST 2023, time=2023-09-06, status=1, ipAttribution=北京)]

2023-11-09 Zhou zhongsheng 来自吉林省

偏重的研究方向：生物材料
经验分享：两个月了没有审稿人

26 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：状态是with editor 之后变成 decision in process，这个状态要持续多久呀，已经一个礼拜了，也不送审。可以直接投下一个期刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向：生物材料 经验分享：两个月了没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2166390, encodeId=9a102166390e1, content=cancer letters转投过来的，2023.10.25submit 2023.10.26with editor 2023.11.01under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0052564025, createdName=1256bf87m89暂无昵称, createdTime=Thu Nov 02 23:04:48 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2156965, encodeId=d654215696515, content=有大佬分享一下投稿时间线么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Sun Sep 10 09:07:05 CST 2023, time=2023-09-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158566, encodeId=6695215856645, content=这杂志咋进不去投稿界面？有没有知道咋回事的朋友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e48357893, createdName=ms6000001057089173, createdTime=Tue Sep 19 20:37:59 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156337, encodeId=2821215633e8e, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：6月2号提交，月底外审（中间变过两次日期），8月28号DIP，到现在没有信~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Wed Sep 06 09:22:18 CST 2023, time=2023-09-06, status=1, ipAttribution=北京)]

2023-11-02 1256bf87m89暂无昵称来自陕西省

cancer letters转投过来的，2023.10.25submit 2023.10.26with editor 2023.11.01under review

29 0

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：状态是with editor 之后变成 decision in process，这个状态要持续多久呀，已经一个礼拜了，也不送审。可以直接投下一个期刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向：生物材料 经验分享：两个月了没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2166390, encodeId=9a102166390e1, content=cancer letters转投过来的，2023.10.25submit 2023.10.26with editor 2023.11.01under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0052564025, createdName=1256bf87m89暂无昵称, createdTime=Thu Nov 02 23:04:48 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2156965, encodeId=d654215696515, content=有大佬分享一下投稿时间线么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Sun Sep 10 09:07:05 CST 2023, time=2023-09-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158566, encodeId=6695215856645, content=这杂志咋进不去投稿界面？有没有知道咋回事的朋友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e48357893, createdName=ms6000001057089173, createdTime=Tue Sep 19 20:37:59 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156337, encodeId=2821215633e8e, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：6月2号提交，月底外审（中间变过两次日期），8月28号DIP，到现在没有信~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Wed Sep 06 09:22:18 CST 2023, time=2023-09-06, status=1, ipAttribution=北京)]

2023-09-10 科研小黑来自湖北省

有大佬分享一下投稿时间线么？

39 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：状态是with editor 之后变成 decision in process，这个状态要持续多久呀，已经一个礼拜了，也不送审。可以直接投下一个期刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向：生物材料 经验分享：两个月了没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2166390, encodeId=9a102166390e1, content=cancer letters转投过来的，2023.10.25submit 2023.10.26with editor 2023.11.01under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0052564025, createdName=1256bf87m89暂无昵称, createdTime=Thu Nov 02 23:04:48 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2156965, encodeId=d654215696515, content=有大佬分享一下投稿时间线么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Sun Sep 10 09:07:05 CST 2023, time=2023-09-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158566, encodeId=6695215856645, content=这杂志咋进不去投稿界面？有没有知道咋回事的朋友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e48357893, createdName=ms6000001057089173, createdTime=Tue Sep 19 20:37:59 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156337, encodeId=2821215633e8e, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：6月2号提交，月底外审（中间变过两次日期），8月28号DIP，到现在没有信~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Wed Sep 06 09:22:18 CST 2023, time=2023-09-06, status=1, ipAttribution=北京)]

2023-09-19 ms6000001057089173 来自江苏省

这杂志咋进不去投稿界面？有没有知道咋回事的朋友

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2170911, encodeId=33c021e09112b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：状态是with editor 之后变成 decision in process，这个状态要持续多久呀，已经一个礼拜了，也不送审。可以直接投下一个期刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20535460863, createdName=ms2000001577708140, createdTime=Sat Nov 25 12:53:20 CST 2023, time=2023-11-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2106235, encodeId=347b210623503, content=投稿一个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211226/b81eecd114f947a4b95c452618e5ebdc/32dc8969e6744e21929a0d643f10b777.jpg, createdBy=404c107315, createdName=Marvin2014, createdTime=Thu Dec 15 20:44:34 CST 2022, time=2022-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2141072, encodeId=008d21410e2f0, content=10号投稿，当天with editor。15号变成decision，现在还在等待决定。已经快一个月了，有相同经历的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb75418039, createdName=gyoun9, createdTime=Tue Jun 06 14:51:37 CST 2023, time=2023-06-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167530, encodeId=2f27216e53014, content=偏重的研究方向：生物材料 经验分享：两个月了没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=Zhou zhongsheng, createdTime=Thu Nov 09 09:47:55 CST 2023, time=2023-11-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2166390, encodeId=9a102166390e1, content=cancer letters转投过来的，2023.10.25submit 2023.10.26with editor 2023.11.01under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0052564025, createdName=1256bf87m89暂无昵称, createdTime=Thu Nov 02 23:04:48 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2156965, encodeId=d654215696515, content=有大佬分享一下投稿时间线么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c266511434, createdName=科研小黑, createdTime=Sun Sep 10 09:07:05 CST 2023, time=2023-09-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158566, encodeId=6695215856645, content=这杂志咋进不去投稿界面？有没有知道咋回事的朋友, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e48357893, createdName=ms6000001057089173, createdTime=Tue Sep 19 20:37:59 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156337, encodeId=2821215633e8e, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：6月2号提交，月底外审（中间变过两次日期），8月28号DIP，到现在没有信~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Wed Sep 06 09:22:18 CST 2023, time=2023-09-06, status=1, ipAttribution=北京)]

2023-09-06 胡同串子羊来自北京

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：分子生物学
经验分享：6月2号提交，月底外审（中间变过两次日期），8月28号DIP，到现在没有信~

32 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务